TN HB 1968
died on adjournmentOpioids - As enacted, adds Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to the list of companies that may be released by the attorney general for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33.
Tennessee · 114S1 · lower
Quick answers
Did TN HB 1968 pass?
No. TN HB 1968 died when the 114S1 session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-05-18): Comp. became Pub. Ch. 888
What is TN HB 1968 about?
TN HB 1968 is a bill in the 114S1 titled “Opioids - As enacted, adds Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to the list of companies that may be released by the attorney general for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33.”.
Who sponsors TN HB 1968?
Farmer is the primary sponsor of TN HB 1968.
- Introduced
- 2026-02-02
- Latest action
- 2026-05-18 — Comp. became Pub. Ch. 888
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- Farmerprimary
Committees
Not provided by source.
Action timeline
2026-01-22
Filed for introduction
filing
2026-02-02
Intro., P1C.
introduction
2026-02-04
Placed on s/c cal Civil Justice Subcommittee for 2/11/2026
2026-02-04
Assigned to s/c Civil Justice Subcommittee
referral-committee
2026-02-04
P2C, ref. to Judiciary Committee
referral-committee
2026-02-11
Placed on s/c cal Civil Justice Subcommittee for 2/18/2026
2026-02-11
Action Def. in s/c Civil Justice Subcommittee to 2/18/2026
2026-02-18
Rec. for pass by s/c ref. to Judiciary Committee
committee-passage-favorable
2026-02-25
Placed on cal. Judiciary Committee for 3/4/2026
2026-03-04
Placed on cal. Judiciary Committee for 3/11/2026
2026-03-04
Action def. in Judiciary Committee to 3/11/2026
2026-03-11
Assigned to s/c Finance, Ways, and Means Subcommittee
referral-committee
2026-03-11
Rec. for pass; ref to Finance, Ways, and Means Committee
committee-passage-favorable
2026-03-25
Placed on s/c cal Finance, Ways, and Means Subcommittee for 4/1/2026
2026-04-01
Placed on cal. Finance, Ways, and Means Committee for 4/7/2026
2026-04-01
Rec. for pass by s/c ref. to Finance, Ways, and Means Committee
committee-passage-favorable
2026-04-07
Rec. for pass; ref to Calendar & Rules Committee
committee-passage-favorable
2026-04-08
Placed on cal. Calendar & Rules Committee for 4/9/2026
2026-04-09
H. Placed on Consent Calendar for 4/13/2026
2026-04-13
H. Placed on Regular Calendar for 4/14/2026
2026-04-13
Objected to on Consent Calendar.
2026-04-16
Comp. SB subst.
2026-05-18
Comp. became Pub. Ch. 888
Versions
Documents
- application/pdf(no extracted text yet)
- (no extracted text yet)
Votes
HOUSE CIVIL JUSTICE SUBCOMMITTEE: Rec. for pass by s/c ref. to Judiciary Committee 2/18/2026 Passed (4)
2026-02-18 · pass · 8-0
HOUSE JUDICIARY COMMITTEE: Rec. for pass; ref to Finance, Ways, and Means Committee 3/11/2026 Passed
2026-03-11 · pass · 16-0
HOUSE FINANCE, WAYS, AND MEANS SUBCOMMITTEE: Rec. for pass by s/c ref. to Finance, Ways, and Means Committee 4/1/2026 Passed (3)
2026-04-01 · pass · 13-0
HOUSE FINANCE, WAYS, AND MEANS COMMITTEE: Rec. for pass; ref to Calendar & Rules Committee 4/7/2026 Passed (2)
2026-04-07 · pass · 27-0
HOUSE CALENDAR & RULES COMMITTEE: H. Placed on Consent Calendar 4/9/2026 (1)
2026-04-09 · fail · 0-0
Related bills
- Companion bill: SB 1495
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:32:51.339172Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=TN&identifier=HB 1968. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
- Some documents have no extracted text yet, so version comparison may be limited.
See the methodology page for data sources and limitations.